Registered entities
Noxxon Pharma Ag
Reg. No. HRB65553Germany
Innovation
40 patent families (28 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 2,901 times.
| Year | Filings |
|---|---|
| 2012 | 19 |
| 2013 | 15 |
| 2014 | 14 |
| 2015 | 13 |
| 2016 | 11 |
| 2017 | 9 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 6 |
Investor mix
18 investors on record; lead investors include NGN Capital, Dow Chemical Company, DEWB.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 44% |
| Private equity | 2 | 11% |
| Bank & private debt | 4 | 22% |
| Other / undisclosed | 4 | 22% |